Agenus (NASDAQ:AGEN) Rating Increased to Buy at HC Wainwright
HC Wainwright upgraded shares of Agenus (NASDAQ:AGEN – Free Report) from a neutral rating to a buy rating in a report released on Wednesday morning, Marketbeat reports. The firm currently has $25.00 price target on the biotechnology company’s stock. Other equities research analysts have also issued reports about the company. Wall Street Zen upgraded Agenus […]
HC Wainwright upgraded shares of Agenus (NASDAQ:AGEN – Free Report) from a neutral rating to a buy rating in a report released on Wednesday morning, Marketbeat reports. The firm currently has $25.00 price target on the biotechnology company’s stock. Other equities research analysts have also issued reports about the company. Wall Street Zen upgraded Agenus […]
